Tests for evaluating non-immediate allergic drug reactions

References

• Thong BY, Leong KP, Tang CY, Chng HH. Drug allergy in a general hospital: results of a novel prospective inpatient reporting system. Ann Allergy Asthma Immunol 2003;90(3):342-7
   PubMed Web of Science ®Google Scholar
• Sastre J, Manso L, Sanchez-Garcia S, Fernandez-Nieto M. Medical and economic impact of misdiagnosis of drug hypersensitivity in hospitalized patients. J Allergy Clin Immunol 2012;129(2):566-7
   PubMed Web of Science ®Google Scholar
• Torres MJ, Blanca M, Fernandez J, et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003;58(10):961-72
   PubMed Web of Science ®Google Scholar
• Brockow K, Romano A, Blanca M, et al. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002;57(1):45-51
   PubMed Web of Science ®Google Scholar
• Romano A, Blanca M, Torres MJ, et al. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 2004;59(11):1153-60
   PubMed Web of Science ®Google Scholar
• Romano A, Torres MJ, Castells M, et al. Diagnosis and management of drug hypersensitivity reactions. J Allergy Clin Immunol 2011;127(Suppl 3):S67-73
   Web of Science ®Google Scholar
• Caubet JC, Kaiser L, Lemaitre B, et al. The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge. J Allergy Clin Immunol 2011;127(1):218-22
   PubMed Web of Science ®Google Scholar
• Torres MJ, Corzo JL, Leyva L, et al. Differences in the immunological responses in drug- and virus-induced cutaneous reactions in children. Blood Cells Mol Dis 2003;30(1):124-31
   PubMed Web of Science ®Google Scholar
• Coombs RR, Gell PG. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Clinical aspects of immunology Gell. Coombs RR, Lachmann PJ, editors. Blackwell Scientific Publications; 1975. p. 575-96
   Google Scholar
• Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003;139(8):683-93
   PubMed Web of Science ®Google Scholar
• Blanca M, Posadas S, Torres MJ, et al. Expression of the skin-homing receptor in peripheral blood lymphocytes from subjects with nonimmediate cutaneous allergic drug reactions. Allergy 2000;55(11):998-1004
   PubMed Web of Science ®Google Scholar
• Ramirez-Gonzalez MD, Herrera-Enriquez M, Villanueva-Rodriguez LG, Castell-Rodriguez AE. Role of epidermal dendritic cells in drug-induced cutaneous adverse reactions. Handb Exp Pharmacol 2009(188):137-62
   PubMedGoogle Scholar
• Ariza A, Garzon D, Abanades DR, et al. Protein haptenation by amoxicillin: high resolution mass spectrometry analysis and identification of target proteins in serum. J Proteom 2012;77:504-20
   PubMed Web of Science ®Google Scholar
• Brander C, Mauri-Hellweg D, Bettens F, et al. Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals. J Immunol 1995;155(5):2670-8
   PubMed Web of Science ®Google Scholar
• Padovan E, Bauer T, Tongio MM, et al. Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur J Immunol 1997;27(6):1303-7
   PubMed Web of Science ®Google Scholar
• Torres MJ, Mayorga C, Fernandez TD, et al. T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence. Int J Immunopathol Pharmacol 2006;19(1):119-30
   PubMed Web of Science ®Google Scholar
• Caproni M, Volpi W, Macchia D, et al. Infiltrating cells and related cytokines in lesional skin of patients with chronic idiopathic urticaria and positive autologous serum skin test. Exp Dermatol 2003;12(5):621-8
   PubMed Web of Science ®Google Scholar
• Hossny E, Aboul-Magd M, Bakr S. Increased plasma eotaxin in atopic dermatitis and acute urticaria in infants and children. Allergy 2001;56(10):996-1002
   PubMed Web of Science ®Google Scholar
• Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001;137(6):765-70
   PubMed Web of Science ®Google Scholar
• Nadarajah K, Green GR, Naglak M. Clinical outcomes of penicillin skin testing. Ann Allergy Asthma Immunol 2005;95(6):541-5
   PubMed Web of Science ®Google Scholar
• Fernandez TD, Canto G, Blanca M. Molecular mechanisms of maculopapular exanthema. Curr Opin Infect Dis 2009;22(3):272-8
   PubMed Web of Science ®Google Scholar
• Yawalkar N, Shrikhande M, Hari Y, et al. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J Allergy Clin Immunol 2000;106(6):1171-6
   PubMed Web of Science ®Google Scholar
• Tsuge I, Okumura A, Kondo Y, et al. Allergen-specific T-cell response in patients with phenytoin hypersensitivity; simultaneous analysis of proliferation and cytokine production by carboxyfluorescein succinimidyl ester (CFSE) dilution assay. Allergol Int 2007;56(2):149-55
   PubMedGoogle Scholar
• Park HJ, Kim HS, Kim HJ, et al. Immunohistochemical characterization of cutaneous drug eruptions by STI571. J Dermatol Sci 2005;38(1):9-15
   PubMed Web of Science ®Google Scholar
• Yawalkar N, Egli F, Hari Y, et al. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy 2000;30(6):847-55
   PubMed Web of Science ®Google Scholar
• Posadas SJ, Padial A, Torres MJ, et al. Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J Allergy Clin Immunol 2002;109(1):155-61
   PubMed Web of Science ®Google Scholar
• Fernandez TD, Mayorga C, Torres MJ, et al. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs. Allergy 2008;63(6):712-19
   PubMed Web of Science ®Google Scholar
• Cornejo-Garcia JA, Fernandez TD, Torres MJ, et al. Differential cytokine and transcription factor expression in patients with allergic reactions to drugs. Allergy 2007;62(12):1429-38
   PubMed Web of Science ®Google Scholar
• Mullen AC, High FA, Hutchins AS, et al. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 2001;292(5523):1907-10
   PubMed Web of Science ®Google Scholar
• Soler D, Humphreys TL, Spinola SM, Campbell JJ. CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. Blood 2003;101(5):1677-82
   PubMed Web of Science ®Google Scholar
• Shimada Y, Takehara K, Sato S. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J Dermatol Sci 2004;34(3):201-8
   PubMed Web of Science ®Google Scholar
• Tapia B, Morel E, Martin-Diaz MA, et al. Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema. Clin Exp Allergy 2007;37(5):704-13
   PubMed Web of Science ®Google Scholar
• Homey B, Alenius H, Muller A, et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002;8(2):157-65
   PubMed Web of Science ®Google Scholar
• Flier J, Boorsma DM, van Beek PJ, et al. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 2001;194(4):398-405
   PubMed Web of Science ®Google Scholar
• Hunziker T, Kunzi UP, Braunschweig S, et al. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy 1997;52(4):388-93
   PubMed Web of Science ®Google Scholar
• Ozkaya E. Fixed drug eruption: state of the art. J Dtsch Dermatol Ges 2008;6(3):181-8
   PubMed Web of Science ®Google Scholar
• Shiohara T, Mizukawa Y. Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells. Eur J Dermatol 2007;17(3):201-8
   PubMed Web of Science ®Google Scholar
• Mizukawa Y, Yamazaki Y, Shiohara T. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption. Br J Dermatol 2008;158(6):1230-8
   PubMed Web of Science ®Google Scholar
• Shiohara T. Fixed drug eruption: pathogenesis and diagnostic tests. Curr Opin Allergy Clin Immunol 2009;9(4):316-21
   PubMed Web of Science ®Google Scholar
• Saint-Mezard P, Rosieres A, Krasteva M, et al. Allergic contact dermatitis. Eur J Dermatol 2004;14(5):284-95
   PubMed Web of Science ®Google Scholar
• Kochevar IE, Harber LC. Photoreactions of 3,3’,4’,5-tetrachlorosalicylanilide with proteins. J Invest Dermatol 1977;68(3):151-6
   PubMed Web of Science ®Google Scholar
• Marutani K, Otabe Y, Nagamuta M, et al. Photoallergenicity of a fluoroquinolone antibacterial agent with a fluorine substituent at the 8-position in guinea pigs exposed to long-wavelength UV light. Skin Pharmacol Physiol 1998;11(4-5):232-40
   Web of Science ®Google Scholar
• Trautmann A, Akdis M, Kleemann D, et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 2000;106(1):25-35
   PubMed Web of Science ®Google Scholar
• Pennino D, Eyerich K, Scarponi C, et al. IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes. J Immunol 2010;184(9):4880-8
   PubMed Web of Science ®Google Scholar
• Saint-Mezard P, Berard F, Dubois B, et al. The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis. Eur J Dermatol 2004;14(3):131-8
   PubMed Web of Science ®Google Scholar
• Cavani A, Nasorri F, Ottaviani C, et al. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J Immunol 2003;171(11):5760-8
   PubMed Web of Science ®Google Scholar
• Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part I. Clinical perspectives. J Am Acad Dermatol 2013;68(5):693; e691-614; quiz 706-698
   PubMed Web of Science ®Google Scholar
• Kano Y, Shiohara T. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin North Am 2009;29(3):481-501
   PubMed Web of Science ®Google Scholar
• Borroni G, Torti S, Pezzini C, et al. Histopathologic spectrum of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a diagnosis that needs clinico-pathological correlation. G Ital Dermatol Venereol 2014;149(3):291-300
   PubMed Web of Science ®Google Scholar
• Roujeau JC, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991;127(9):1333-8
   PubMedGoogle Scholar
• Britschgi M, Pichler WJ. Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells. Curr Opin Allergy Clin Immunol 2002;2(4):325-31
   PubMed Web of Science ®Google Scholar
• Padial MA, Alvarez-Ferreira J, Tapia B, et al. Acute generalized exanthematous pustulosis associated with pseudoephedrine. Br J Dermatol 2004;150(1):139-42
   PubMed Web of Science ®Google Scholar
• Schaerli P, Britschgi M, Keller M, et al. Characterization of human T cells that regulate neutrophilic skin inflammation. J Immunol 2004;173(3):2151-8
   PubMed Web of Science ®Google Scholar
• Halevy S. Acute generalized exanthematous pustulosis. Curr Opin Allergy Clin Immunol 2009;9(4):322-8
   PubMed Web of Science ®Google Scholar
• Kabashima R, Sugita K, Sawada Y, et al. Increased circulating Th17 frequencies and serum IL-22 levels in patients with acute generalized exanthematous pustulosis. J Eur Acad Dermatol Venereol 2011;25(4):485-8
   PubMed Web of Science ®Google Scholar
• Lipowicz S, Sekula P, Ingen-Housz-Oro S, et al. Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 2013;168(4):726-32
   PubMed Web of Science ®Google Scholar
• Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005;209(2):123-9
   PubMed Web of Science ®Google Scholar
• Neuman M, Nicar M. Apoptosis in ibuprofen-induced Stevens-Johnson syndrome. Transl Res 2007;149(5):254-9
   PubMed Web of Science ®Google Scholar
• Mayorga C, Torres MJ, Corzo JL, et al. Improvement of toxic epidermal necrolysis after the early administration of a single high dose of intravenous immunoglobulin. Ann Allergy Asthma Immunol 2003;91(1):86-91
   PubMed Web of Science ®Google Scholar
• Tapia B, Padial A, Sanchez-Sabate E, et al. Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions. J Allergy Clin Immunol 2004;114(2):335-40
   PubMed Web of Science ®Google Scholar
• Abe R, Shimizu T, Shibaki A, et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am J Pathol 2003;162(5):1515-20
   PubMed Web of Science ®Google Scholar
• Lowin B, Peitsch MC, Tschopp J. Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr Top Microbiol Immunol 1995;198:1-24
   PubMedGoogle Scholar
• Chung WH, Hung SI, Yang JY, et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008;14(12):1343-50
   PubMed Web of Science ®Google Scholar
• Hogg AE, Bowick GC, Herzog NK, et al. Induction of granulysin in CD8+ T cells by IL-21 and IL-15 is suppressed by human immunodeficiency virus-1. J Leukoc Biol 2009;86(5):1191-203
   PubMed Web of Science ®Google Scholar
• Bellon T, Alvarez L, Mayorga C, et al. Differential gene expression in drug hypersensitivity reactions: induction of alarmins in severe bullous diseases. Br J Dermatol 2010;162(5):1014-22
   PubMed Web of Science ®Google Scholar
• Barbaud A. Skin testing in delayed reactions to drugs. Immunol Allergy Clin North Am 2009;29(3):517-35
   PubMed Web of Science ®Google Scholar
• Aberer W, Bircher A, Romano A, et al. European Network for Drug Allergy. EAACI interest group on drug hypersensitivity. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003;58(9):854-63
   PubMed Web of Science ®Google Scholar
• Mayorga C, Torres MJ, Fernandez J, et al. Cutaneous symptoms in drug allergy: what have we learnt? Curr Opin Allergy Clin Immunol 2009;9(5):431-6
   PubMed Web of Science ®Google Scholar
• Barbaud A. Drug patch testing in systemic cutaneous drug allergy. Toxicology 2005;209(2):209-16
   PubMed Web of Science ®Google Scholar
• Padial A, Antunez C, Blanca-Lopez N, et al. Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test. Clin Exp Allergy 2008;38(5):822-8
   PubMed Web of Science ®Google Scholar
• Barbaud A, Goncalo M, Bruynzeel D, Bircher A; European Society of Contact D. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermat 2001;45(6):321-8
   PubMed Web of Science ®Google Scholar
• Barbaud A. Skin testing and patch testing in non-IgE-mediated drug allergy. Curr Allergy Asthma Rep 2014;14(6):442
   PubMed Web of Science ®Google Scholar
• Barbaud A, Collet E, Milpied B, et al. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol 2013;168(3):555-62
   PubMed Web of Science ®Google Scholar
• Terrados S, Blanca M, Garcia J, et al. Nonimmediate reactions to betalactams: prevalence and role of the different penicillins. Allergy 1995;50(7):563-7
   PubMed Web of Science ®Google Scholar
• Romano A, Viola M, Mondino C, et al. Diagnosing nonimmediate reactions to penicillins by in vivo tests. Int Arch Allergy Immunol 2002;129(2):169-74
   PubMed Web of Science ®Google Scholar
• Doña I, Blanca-Lopez N, Torres MJ, et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol 2012;22(5):363-71
   PubMed Web of Science ®Google Scholar
• Casadevall J, Ventura PJ, Mullol J, Picado C. Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry. Thorax 2000;55(11):921-4
   PubMed Web of Science ®Google Scholar
• Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J 2000;15(5):863-9
   PubMed Web of Science ®Google Scholar
• Lehner T. Lignocaine hypersensitivity. Lancet 1971;1(7711):1245-6
   PubMed Web of Science ®Google Scholar
• Hannuksela M, Salo H. The repeated open application test (ROAT). Contact Dermat 1986;14(4):221-7
   PubMed Web of Science ®Google Scholar
• Stur K, Karlhofer FM, Stingl G. Soluble FAS ligand: a discriminating feature between drug-induced skin eruptions and viral exanthemas. J Invest Dermatol 2007;127(4):802-7
   PubMed Web of Science ®Google Scholar
• Mayorga C, Pena RR, Blanca-Lopez N, et al. Monitoring the acute phase response in non-immediate allergic drug reactions. Curr Opin Allergy Clin Immunol 2006;6(4):249-57
   PubMed Web of Science ®Google Scholar
• Morel E, Alvarez L, Cabanas R, et al. Expression of alpha-defensin 1-3 in T cells from severe cutaneous drug-induced hypersensitivity reactions. Allergy 2011;66(3):360-7
   PubMed Web of Science ®Google Scholar
• Mauri-Hellweg D, Bettens F, Mauri D, et al. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995;155(1):462-72
   PubMed Web of Science ®Google Scholar
• Dona I, Blanca-Lopez N, Cornejo-Garcia JA, et al. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy 2011;41(1):86-95
   PubMed Web of Science ®Google Scholar
• Quiralte J, Blanco C, Castillo R, et al. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 1996;98(3):678-85
   PubMed Web of Science ®Google Scholar
• Mayorga C, Sanz ML, Gamboa P, et al. In vitro methods for diagnosing nonimmediate hypersensitivity reactions to drugs. J Investig Allergol Clin Immunol 2013;23(4):213-25; quiz preceding 225
   PubMed Web of Science ®Google Scholar
• Thong BY, Mirakian R, Castells M, et al. A world allergy organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivity. World Allergy Organ J 2011;4(12):257-70
   PubMedGoogle Scholar
• Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004;59(8):809-20
   PubMed Web of Science ®Google Scholar
• Luque I, Leyva L, Jose Torres M, et al. In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 2001;56(7):611-18
   PubMed Web of Science ®Google Scholar
• Gomez E, Perez-Cataldo G, Castell JV, et al. Effect of metabolising cell system in lymphocyte transformation test to evaluate non immediate reaction to anticonvulsants. In: EAACI. Estambul: 2011
   Google Scholar
• Lopez-Rocha E, Blancas L, Rodriguez-Mireles K, et al. Prevalence of DRESS syndrome. Rev Alerg Mex 2014;61(1):14-23
   PubMedGoogle Scholar
• Chaves P, Torres MJ, Aranda A, et al. Natural killer-dendritic cell interaction in lymphocyte responses in hypersensitivity reactions to betalactams. Allergy 2010;65(12):1600-8
   PubMed Web of Science ®Google Scholar
• Lopez S, Torres MJ, Rodriguez-Pena R, et al. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins. Br J Dermatol 2009;160(2):259-65
   PubMed Web of Science ®Google Scholar
• Rodriguez-Pena R, Lopez S, Mayorga C, et al. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams. J Allergy Clin Immunol 2006;118(4):949-56
   PubMed Web of Science ®Google Scholar
• Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997;27(2):175-81
   PubMed Web of Science ®Google Scholar
• Castrejon JL, Berry N, El-Ghaiesh S, et al. Stimulation of human T cells with sulfonamides and sulfonamide metabolites. J Allergy Clin Immunol 2010;125(2):411-18; e414
   PubMed Web of Science ®Google Scholar
• Sanchez-Quintero MJ, Torres MJ, Blazquez AB, et al. Synergistic effect between amoxicillin and TLR ligands on dendritic cells from amoxicillin-delayed allergic patients. PLoS One 2013;8(9):e74198
   PubMed Web of Science ®Google Scholar
• Porebski G, Gschwend-Zawodniak A, Pichler WJ. In vitro diagnosis of T cell-mediated drug allergy. Clin Exp Allergy 2011;41(4):461-70
   PubMed Web of Science ®Google Scholar
• Tanvarasethee B, Buranapraditkun S, Klaewsongkram J. The potential of using enzyme-linked immunospot to diagnose cephalosporin-induced maculopapular exanthems. Acta Derm Venereol 2013;93(1):66-9
   PubMed Web of Science ®Google Scholar
• Maino VC, Suni MA, Ruitenberg JJ. Rapid flow cytometric method for measuring lymphocyte subset activation. Cytometry 1995;20(2):127-33
   PubMedGoogle Scholar
• Illing PT, Vivian JP, Dudek NL, et al. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 2012;486(7404):554-8
   PubMed Web of Science ®Google Scholar